• Dissecting Aneugenic Mechanisms: Insights from 27 Reference

  2026-08-04

  This study introduces a tiered molecular assay for precise identification of aneugenic mechanisms in vitro, distinguishing between microtubule destabilization, stabilization, and mitotic kinase inhibition. The approach provides robust, machine learning-supported tools for mechanistic genotoxicity profiling, with direct implications for research on microtubule-associated inhibitors such as griseofulvin.

• Stiripentol: Modulating Lactate Metabolism for Next-Gen Epil

  2026-08-03

  Discover how Stiripentol, a pioneering LDH inhibitor, enables precise modulation of the astrocyte-neuron lactate shuttle and advances research in both epilepsy and tumor immunometabolism. This article offers novel insights into assay design and translational applications.

• Ibuprofen Toxicology and Biodegradation: Environmental Insig

  2026-08-03

  This review analyzes ibuprofen's dual role as an essential anti-inflammatory agent and an emerging environmental contaminant. The paper highlights the molecule's pharmacological action, environmental persistence, and challenges in biodegradation, with significant implications for both biomedical research and environmental health.

• Tolazoline for Translational Research: Mechanistic Insight a

  2026-08-02

  This article delivers a thought-leadership overview of Tolazoline as a mechanistically validated α2-adrenergic receptor antagonist for in vitro and in vivo translational research. It explores the scientific rationale, experimental best practices, and strategic considerations for optimizing islet function and airway smooth muscle studies, while offering guidance on protocol design and forward-looking applications. Unique to this piece is a nuanced discussion of Tolazoline’s dual-action—spanning adrenergic signaling and ATP-sensitive potassium channel modulation—and a critical comparison to competitive research tools. Anchored in both peer-reviewed and technical evidence, the article provides actionable recommendations for maximizing data integrity and translational value.

• Phosphatase Inhibitor Cocktail: Precision in Protein Phospho

  2026-08-01

  Unlock reproducible phosphorylation analysis with the Phosphatase Inhibitor Cocktail (2 Tubes, 100X), preserving labile modifications essential for kinase assays and immunoblotting. This dual-tube system enables robust serine/threonine and tyrosine phosphatase inhibition, supporting advanced CNS research and translational workflows.

• Acifran: Precision Tool for Lipid Metabolism Signaling Resea

  2026-07-31

  Acifran—(R)-5-methyl-4-oxo-5-phenyl-4,5-dihydrofuran-2-carboxylic acid—brings a new level of receptor selectivity and structural insight to lipid metabolism research. Its integration with state-of-the-art cryo-EM workflows and robust assay design enables unparalleled accuracy in dissecting lipid signaling pathways and advancing metabolic disorder research.

• Jiao-tai-wan/Coptisine Regulates SIRT1 to Attenuate DHEA-PCO

  2026-07-31

  This study elucidates how Jiao-tai-wan (JTW) and its component coptisine attenuate DHEA-induced polycystic ovary syndrome (PCOS) by modulating mitochondrial cholesterol import via suppression of SIRT1 ubiquitination. The findings deepen understanding of herbal intervention mechanisms in PCOS and highlight SIRT1 regulation as a promising therapeutic strategy.

• Selective Human ClpP Activation Induces Cell Cycle Arrest in

  2026-07-30

  The referenced study demonstrates that the selective human mitochondrial serine protease ClpP activator ZK53 can disrupt mitochondrial function and induce cell cycle arrest in lung squamous cell carcinoma (LUSC) models. This mechanistic insight advances the field of mitochondrial-targeted oncology by providing a potent and specific chemical tool for dissecting ClpP-mediated cancer vulnerabilities.

• Cy7 NHS Ester: Technical Guide for Protein Labeling and NIR

  2026-07-30

  Cy7 NHS ester offers a robust solution for labeling proteins and peptides with a sulfonated near-infrared dye, supporting advanced bioimaging workflows where water solubility and minimized quenching are critical. It is ideal for applications requiring high sensitivity and minimal denaturation, but extended storage of dye solutions and use with non-amine targets should be avoided.

• APEX2 Regulates TERT Expression via MIR Elements in hESCs

  2026-07-29

  This study reveals that APEX2, but not APEX1, is essential for efficient expression of the TERT gene in human embryonic stem cells, uncovering a novel regulatory mechanism involving APEX2 binding to MIR repetitive elements within TERT. These findings expand the understanding of telomerase regulation in stem cell biology and have implications for research in aging and cancer.

• CLCC1 as a Key Host Factor in Herpesvirus Nuclear Egress

  2026-07-29

  The reference study identifies the host chloride channel CLCC1 as essential for the membrane fusion step during herpesvirus nuclear egress, a previously uncharacterized stage in viral replication. These findings provide mechanistic insight into herpesvirus biology and highlight new opportunities for host-targeted antiviral strategies.

• Ceftolozane/Tazobactam: Addressing Gram-Negative Resistance

  2026-07-28

  Ceftolozane/tazobactam represents a significant advancement in combating multidrug-resistant gram-negative pathogens, especially Pseudomonas aeruginosa and ESBL-producing Enterobacteriaceae. This review dissects its mechanism, pharmacodynamic advantages, and clinical relevance, offering context for researchers studying antibacterial strategies.

• Peripheral Immune Dysregulation in Adolescent MDD: RNA-Seq I

  2026-07-28

  This study integrates bulk and single-cell RNA sequencing to reveal a suppressed peripheral immune signature in adolescents with major depressive disorder (MDD). The findings highlight both widespread downregulation of immune genes and limited impact of current antidepressant treatments, suggesting a need for new therapeutic targets focused on immune pathways.

• Trichostatin A (TSA): HDAC Inhibition, Tumor Immunogenicity,

  2026-07-27

  Explore the multifaceted role of Trichostatin A (TSA) as a potent HDAC inhibitor in modulating tumor immunogenicity and epigenetic regulation in cancer. This article uniquely bridges molecular mechanisms with translational assay strategy, offering researchers advanced guidance beyond standard protocols.

• U0126 and the MEK1/2 Nexus: Rethinking Translational Pain Re

  2026-07-27

  Explore how U0126, a potent MEK1/2 inhibitor from APExBIO, is reshaping experimental design in translational neurobiology and cancer research. This thought-leadership article connects recent mechanistic breakthroughs—such as ERK1/2’s role in peripheral sensitization during orofacial pain—to strategic guidance for researchers. Drawing upon new evidence and APExBIO’s product intelligence, it offers actionable insights and protocol parameters, while forecasting the next advances in the MAPK/ERK pathway inhibition landscape.

449 records 9/30 page Previous Next First page 上5页 678910 下5页 Last page